about
Barriers and Challenges in Hyperemesis Gravidarum ResearchThe delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancyTreatment options for hyperemesis gravidarum.Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies.Hyperemesis gravidarum affects maternal sanity, thyroid hormones and fetal health: a prospective case control study.Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum.Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.
P2860
Q26766280-38AB45FB-531F-4BD6-9489-BFDFA82A11E6Q28308072-D1623F7E-C1AB-46B9-B194-99A9653FA99AQ39077715-B1F193BB-39FC-4214-B531-1C6CED771EB0Q39717414-8FDF1806-5E43-4705-A03D-25A12C854D22Q41501249-CBD769CB-5E99-4ADB-9CED-54363679506CQ46870141-5669F8C8-07D2-478B-884F-391840FA8F39Q47555157-0543B231-B94D-4151-A29B-A518E29EB0FE
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recurrence risk of hyperemesis gravidarum
@ast
Recurrence risk of hyperemesis gravidarum
@en
Recurrence risk of hyperemesis gravidarum
@nl
type
label
Recurrence risk of hyperemesis gravidarum
@ast
Recurrence risk of hyperemesis gravidarum
@en
Recurrence risk of hyperemesis gravidarum
@nl
prefLabel
Recurrence risk of hyperemesis gravidarum
@ast
Recurrence risk of hyperemesis gravidarum
@en
Recurrence risk of hyperemesis gravidarum
@nl
P2093
P2860
P1476
Recurrence risk of hyperemesis gravidarum
@en
P2093
Marlena S Fejzo
Patrick M Mullin
T Murphy Goodwin
P2860
P304
P356
10.1111/J.1542-2011.2010.00019.X
P577
2011-03-01T00:00:00Z